225 related articles for article (PubMed ID: 28632001)
1. Vasodilator responsiveness in idiopathic pulmonary arterial hypertension: identifying a distinct phenotype with distinct physiology and distinct prognosis.
Langleben D; Orfanos S
Pulm Circ; 2017; 7(3):588-597. PubMed ID: 28632001
[TBL] [Abstract][Full Text] [Related]
2. Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension.
Hemnes AR; Zhao M; West J; Newman JH; Rich S; Archer SL; Robbins IM; Blackwell TS; Cogan J; Loyd JE; Zhao Z; Gaskill C; Jetter C; Kropski JA; Majka SM; Austin ED
Am J Respir Crit Care Med; 2016 Aug; 194(4):464-75. PubMed ID: 26926454
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of acute vasodilator response in pulmonary arterial hypertension: beyond the "classic" responders.
Halliday SJ; Hemnes AR; Robbins IM; Pugh ME; Zhao DX; Piana RN; Fong PP; Brittain EL
J Heart Lung Transplant; 2015 Mar; 34(3):312-8. PubMed ID: 25577565
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension.
Hemnes AR; Trammell AW; Archer SL; Rich S; Yu C; Nian H; Penner N; Funke M; Wheeler L; Robbins IM; Austin ED; Newman JH; West J
Circulation; 2015 Jan; 131(4):401-9; discussion 409. PubMed ID: 25361553
[TBL] [Abstract][Full Text] [Related]
5. Acute Vasodilator Response in Pediatric Pulmonary Arterial Hypertension: Current Clinical Practice From the TOPP Registry.
Douwes JM; Humpl T; Bonnet D; Beghetti M; Ivy DD; Berger RM;
J Am Coll Cardiol; 2016 Mar; 67(11):1312-23. PubMed ID: 26988953
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension.
Tonelli AR; Alnuaimat H; Mubarak K
Respir Med; 2010 Apr; 104(4):481-96. PubMed ID: 20004088
[TBL] [Abstract][Full Text] [Related]
7. Effect of calcium channel blockers evaluated by cardiopulmonary exercise testing in idiopathic pulmonary arterial hypertension responding to acute pulmonary vasoreactivity testing.
Tang Y; Yao L; Liu Z; Ma X; Luo Q; Zhao Z; Huang Z; Tu L; Gao L; Jin Q; Ni X; Xiong C
Pulm Pharmacol Ther; 2017 Apr; 43():26-31. PubMed ID: 28159512
[TBL] [Abstract][Full Text] [Related]
8. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C
Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243
[TBL] [Abstract][Full Text] [Related]
9. PeakP
Luo CJ; Qiu HL; Wu CW; He J; Yuan P; Zhao QH; Jiang R; Wu WH; Gong SG; Guo J; Zhang R; Liu JM; Wang L
Pulm Circ; 2021; 11(4):20458940211059713. PubMed ID: 34881019
[TBL] [Abstract][Full Text] [Related]
10. Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria.
Douwes JM; van Loon RL; Hoendermis ES; Vonk-Noordegraaf A; Roofthooft MT; Talsma MD; Hillege HL; Berger RM
Eur Heart J; 2011 Dec; 32(24):3137-46. PubMed ID: 21893489
[TBL] [Abstract][Full Text] [Related]
11. Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.
Yuan YP; Yuan P; Su YL; Jiang R; Zhang R; He J; Qiu HL; Luo CJ; Liu JM; Gong SG; Wang L; Zhao QH
Clin Rheumatol; 2022 Jun; 41(6):1675-1686. PubMed ID: 35099674
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease.
Latus H; Wagner I; Ostermayer S; Kerst G; Kreuder J; Schranz D; Apitz C
Pediatr Cardiol; 2017 Oct; 38(7):1342-1349. PubMed ID: 28681131
[TBL] [Abstract][Full Text] [Related]
13. Evidence-based pharmacologic management of pulmonary arterial hypertension.
Benedict N; Seybert A; Mathier MA
Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
[TBL] [Abstract][Full Text] [Related]
14. Identifying microRNAs targeting Wnt/β-catenin pathway in end-stage idiopathic pulmonary arterial hypertension.
Wu D; Talbot CC; Liu Q; Jing ZC; Damico RL; Tuder R; Barnes KC; Hassoun PM; Gao L
J Mol Med (Berl); 2016 Aug; 94(8):875-85. PubMed ID: 27188753
[TBL] [Abstract][Full Text] [Related]
15. Red blood cell distribution width predicts responsiveness of acute pulmonary vasodilator testing in patients with idiopathic pulmonary arterial hypertension.
Xi Q; Liu Z; Zhao Z; Luo Q
Clin Chim Acta; 2015 Jun; 446():272-6. PubMed ID: 25966828
[TBL] [Abstract][Full Text] [Related]
16. Loss of response to calcium channel blockers after long-term follow-up treatment in patients with idiopathic pulmonary arterial hypertension.
Piloto B; Fernandes CJCDS; Jardim C; Castro M; Alves-Jr JL; Souza R
J Bras Pneumol; 2023; 49(3):e20220337. PubMed ID: 37132695
[TBL] [Abstract][Full Text] [Related]
17. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.
Corrado A; Correale M; Mansueto N; Monaco I; Carriero A; Mele A; Colia R; Di Biase M; Cantatore FP
Microvasc Res; 2017 Nov; 114():46-51. PubMed ID: 28619664
[TBL] [Abstract][Full Text] [Related]
18. High CD200 Expression on T CD4+ and T CD8+ Lymphocytes as a Non-Invasive Marker of Idiopathic Pulmonary Hypertension-Preliminary Study.
Tomaszewski M; Grywalska E; Topyła-Putowska W; Błaszczak P; Kurzyna M; Roliński J; Kopeć G
J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33804413
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary arterial hypertension sensitive to calcium channel blocker, but not advanced pulmonary hypertension treatment: a case report.
Hirakawa K; Aoki T; Tsuji A; Ogo T
Eur Heart J Case Rep; 2022 Sep; 6(9):ytac351. PubMed ID: 36072422
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension.
Langleben D; Orfanos SE; Giovinazzo M; Hirsch A; Baron M; Senécal JL; Armaganidis A; Catravas JD
Arthritis Rheum; 2008 Apr; 58(4):1156-64. PubMed ID: 18383374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
